Website Prevent Cancer Foundation
Prevent Cancer Foundation is supporting research projects focused on cancers without U.S. guideline-recommended screening methods for people of average risk. They seek to address a critical gap with potential for significant impact. Investing in research focused on cancer prevention, early detection, risk stratification and novel screening approaches for these cancers represents an opportunity to fundamentally change survival trajectories.
The nominee must be a professor (any level) or postdoctoral researcher with a project that meets the criteria below. Each total award is limited to $100,000 for a two-year grant period. UCI can have three applications in Track 1 (UCI is not eligible for Track 2).
They invite applications that focus on the following cancer types:
- Blood (leukemia/lymphoma)
- Bone
- Brain (central nervous system)
- Esophageal
- Head-and-neck
- Liver
- Ovarian
- Pancreatic
- Sarcomas (connective-tissue)
- Stomach (gastric)
- Uterine
Research projects must fall into one of the following four tracks:
- Translational Research: Focuses on translating research findings from the lab into the clinic/community, encompassing various stages of research and development.
- Implementation/Dissemination Science: Focuses on the methods and strategies used to promote the adoption of research findings and evidence-based practice into real world practice.
- Population Health: Explores the causes of cancer, cancer trends and factors that affect the delivery and outcomes of cancer care in specific populations (e.g., the role of environmental, behavioral and genetic factors).
- Clinical Trials and Related Studies: Involves studies on humans or animals to evaluate new medical treatments, diagnostic methods and preventive strategies.
The following will not be considered:
- Applications with a focus on cervical, breast, colorectal, lung, prostate and skin – where U.S. guideline-recommended screening tools currently exist, and pediatric cancers will not be considered for this funding opportunity.
- Tests targeting cancer in more than one type at a time such as multi-cancer detection (MCD) tests will not be considered at this time.
- Applicants who have been funded by the tobacco or vaping industries.
- Studies on therapies for established or advanced cancer.
- Resubmission of the same or slightly revised applications submitted to the Prevent Cancer Foundation in the past three cycles.
The campus may submit no more than three proposals. Submit a paragraph with the following information to mrsmith1@uci.edu by Monday, May 11th that contains:
- Include subject line: Prevent Cancer Internal Competition
- Name, Title
- Department and School
- Cancer focus: blood cancer, brain, ovarian, pancreatic, liver, uterine or other (excludes cancers with established national screening guidelines).
- Research track: Translational Research, Implementation/Dissemination Science, Population Health, and Clinical Trials and Related Studies (Pre-clinical research is accepted as long as a clear translational relationship to cancer prevention or early detection can be demonstrated within five years).
- One paragraph description of research project and how it will advance early detection and prevention efforts for the cancer indicated. Emphasize the innovative components for the project and potential outcomes for patients in the near-term.
For more information, contact Marianne Smith, Senior Director of Corporate and Foundation Relations at mrsmith1@uci.edu. The selected nominees will need to prepare and submit the full application by the sponsor deadline of May 20th.